Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Depreciation & Amortization (CF) (2021 - 2026)

HeartSciences (HSCS) has disclosed Depreciation & Amortization (CF) for 5 consecutive years, with $7006.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 42.64% year-over-year to $7006.0, compared with a TTM value of $27637.0 through Oct 2025, down 25.3%, and an annual FY2025 reading of $37599.0, up 34.8% over the prior year.
  • Depreciation & Amortization (CF) was $7006.0 for Q4 2025 at HeartSciences, down from $7111.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $12215.0 in Q4 2024 and bottomed at $3717.0 in Q1 2024.
  • Average Depreciation & Amortization (CF) over 5 years is $7393.8, with a median of $6919.0 recorded in 2021.
  • Peak annual rise in Depreciation & Amortization (CF) hit 61.68% in 2024, while the deepest fall reached 45.86% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $6601.0 in 2021, then increased by 3.21% to $6813.0 in 2022, then rose by 12.08% to $7636.0 in 2023, then soared by 59.97% to $12215.0 in 2024, then crashed by 42.64% to $7006.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for HSCS at $7006.0 in Q4 2025, $7111.0 in Q3 2025, and $7513.0 in Q2 2025.